Stars Season 2026: Aligning Health Plans and Pharmacies for Success
CMS emphasizes clinical outcomes over patient experience in the 2026 Medicare Advantage Star Ratings. Due to this, some health plans may get off course: missing bonus revenue, member retention targets, and possibly their market position if their response time is too long.
Key takeaways from this whitepaper:
- Recognize the change in 2026: In the ratings for 2026 Stars, CMS is rebalancing the Stars to lower the CAHPS weighting and increase clinical measures’ weightings including adherence, A1c control and CBP.
- Embrace integrated action: Instead of operating in silos, unified action by health plans and pharmacies can deliver measurable Stars lift.
- Prepare for the next wave: It’s important to build early readiness for emerging measures like HOS before its weighting triples in 2027.
Download this whitepaper to learn how Stars rebalancing is going to seriously alter the performance rating level in Medicare Advantage and how health plans and pharmacies can begin to change from parallel to unified action.
Stars Season 2026: Aligning Health Plans and Pharmacies for Success
CMS emphasizes clinical outcomes over patient experience in the 2026 Medicare Advantage Star Ratings. Due to this, some health plans may get off course: missing bonus revenue, member retention targets, and possibly their market position if their response time is too long.
Key takeaways from this whitepaper:
- Recognize the change in 2026: In the ratings for 2026 Stars, CMS is rebalancing the Stars to lower the CAHPS weighting and increase clinical measures’ weightings including adherence, A1c control and CBP.
- Embrace integrated action: Instead of operating in silos, unified action by health plans and pharmacies can deliver measurable Stars lift.
- Prepare for the next wave: It’s important to build early readiness for emerging measures like HOS before its weighting triples in 2027.
Download this whitepaper to learn how Stars rebalancing is going to seriously alter the performance rating level in Medicare Advantage and how health plans and pharmacies can begin to change from parallel to unified action.
Stars Season 2026: Aligning Health Plans and Pharmacies for Success
CMS emphasizes clinical outcomes over patient experience in the 2026 Medicare Advantage Star Ratings. Due to this, some health plans may get off course: missing bonus revenue, member retention targets, and possibly their market position if their response time is too long.
Key takeaways from this whitepaper:
- Recognize the change in 2026: In the ratings for 2026 Stars, CMS is rebalancing the Stars to lower the CAHPS weighting and increase clinical measures’ weightings including adherence, A1c control and CBP.
- Embrace integrated action: Instead of operating in silos, unified action by health plans and pharmacies can deliver measurable Stars lift.
- Prepare for the next wave: It’s important to build early readiness for emerging measures like HOS before its weighting triples in 2027.
Download this whitepaper to learn how Stars rebalancing is going to seriously alter the performance rating level in Medicare Advantage and how health plans and pharmacies can begin to change from parallel to unified action.
